Resilience starts the year with its first deal outside of North America
Manufacturing company Resilience hit several high points in 2022 in securing another funding round and netting partnerships with major players, and now it’s starting the new year with a deal that moves it outside North America for the first time.
On Tuesday, Resilience announced that the Abu Dhabi-based sovereign investors, the Mubadala Investment Company, inked an equity investment. The two parties will collaborate on a biopharma manufacturing plan to build a new manufacturing facility in Abu Dhabi. As per the deal, Mubadala will establish the facility and Resilience will operate it. The Abu Dhabi facility will manufacture a range of products, including therapies for cancer and infectious diseases, along with vaccines and other products.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters